Someone with a lot of money to spend has taken a bullish stance on Regeneron Pharmaceuticals REGN.
And retail traders should know.
We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.
Whether this is an institution or just a wealthy individual, we don't know. But when something this big happens with REGN, it often means somebody knows something is about to happen.
Today, Benzinga's options scanner spotted 10 options trades for Regeneron Pharmaceuticals.
This isn't normal.
The overall sentiment of these big-money traders is split between 50% bullish and 50%, bearish.
Out of all of the options we uncovered, there was 1 put, for a total amount of $62,108, and 9, calls, for a total amount of $825,946..
What's The Price Target?
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $710.0 to $1000.0 for Regeneron Pharmaceuticals over the last 3 months.
Volume & Open Interest Development
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Regeneron Pharmaceuticals's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Regeneron Pharmaceuticals's whale activity within a strike price range from $710.0 to $1000.0 in the last 30 days.
Regeneron Pharmaceuticals Option Volume And Open Interest Over Last 30 Days
Biggest Options Spotted:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|
| REGN | CALL | TRADE | BULLISH | 11/17/23 | $735.00 | $363.2K | 52 | 50 |
| REGN | CALL | SWEEP | BULLISH | 01/17/25 | $1000.00 | $112.2K | 39 | 20 |
| REGN | CALL | TRADE | BEARISH | 11/17/23 | $735.00 | $90.5K | 52 | 10 |
| REGN | CALL | SWEEP | BULLISH | 09/15/23 | $850.00 | $73.9K | 21 | 68 |
| REGN | PUT | SWEEP | NEUTRAL | 01/19/24 | $950.00 | $62.1K | 0 | 4 |
Where Is Regeneron Pharmaceuticals Standing Right Now?
- With a volume of 94,828, the price of REGN is up 1.31% at $795.89.
- RSI indicators hint that the underlying stock may be overbought.
- Next earnings are expected to be released in 84 days.
What The Experts Say On Regeneron Pharmaceuticals:
- Guggenheim has decided to maintain their Buy rating on Regeneron Pharmaceuticals, which currently sits at a price target of $900.
- Morgan Stanley has decided to maintain their Overweight rating on Regeneron Pharmaceuticals, which currently sits at a price target of $912.
- Oppenheimer has decided to maintain their Outperform rating on Regeneron Pharmaceuticals, which currently sits at a price target of $950.
- RBC Capital has decided to maintain their Sector Perform rating on Regeneron Pharmaceuticals, which currently sits at a price target of $820.
- Barclays has decided to maintain their Overweight rating on Regeneron Pharmaceuticals, which currently sits at a price target of $900.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Regeneron Pharmaceuticals, Benzinga Pro gives you real-time options trades alerts.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
